Gantrisin Related Published Studies
Well-designed clinical trials related to Gantrisin (Sulfisoxazole)
Comparative efficacy of erythromycin-sulfisoxazole, cefaclor, amoxicillin or placebo for otitis media with effusion in children. [1991.12]
Well-designed clinical trials possibly related to Gantrisin (Sulfisoxazole)
Adenoidectomy versus chemoprophylaxis and placebo for recurrent acute otitis media in children aged under 2 years: randomised controlled trial. [2004.02.28]
Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome. [2000.06]
Treatment of acute sinusitis in childhood with ceftibuten. [1999.05]
Randomized, double blind comparison of brand and generic antibiotic suspensions: II. A study of taste and compliance in children. [1996.01]
Randomized, double blind comparison of brand and generic antibiotic suspensions: I. A study of taste in adults. [1996.01]
Randomized, controlled trial comparing long-term sulfonamide therapy to ventilation tubes for otitis media with effusion. [1991.08]
[Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides] [1991.06]
[An open randomized trial, Pediazole versus cefaclor in the treatment of acute otitis media in children] [1991.02]
[Acute otitis media in children: a randomized and open clinical trial of the efficacy of 2 major antibiotics (erythromycin ethylsuccinate/acetyl sulfafurazole vs amoxicillin/clavulanic acid)] [1990.02]
The effect of verbal commitment and treatment choice on medication compliance in a pediatric setting. [1987.08]
Other research related to Gantrisin (Sulfisoxazole)
Involvement of imidazoline and opioid receptors in the enhancement of clonidine-induced analgesia by sulfisoxazole. [2010.05]
Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. [1996.01]
Synergistic anti-Pneumocystis carinii effects of erythromycin and sulfisoxazole. [1991]
Other possibly related research studies
Otitis media prevention: non-vaccine prophylaxis. [2000.12.08]
Antimicrobial resistance profiling and DNA Amplification Fingerprinting (DAF) of thermophilic Campylobacter spp. in human, poultry and porcine samples from the Cork region of Ireland. [2000.11]
Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric medicaid population. [1997.10]
Hypercalcemia in a patient with hypoparathyroidism and Nocardia asteroides infection: a novel observation. [1997.08]
Trimethoprim and sulfonamide-associated meningoencephalitis with MRI correlates. [1996.02]
[Treatment of acute otitis media] [1995.01]
Urolithiasis as a hazard of sulfonamide therapy. [1994.12]
Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions. [1994.09]
Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex. [1994.07.01]
Antitumor effects of rhodium (II) complexes on mice bearing Ehrlich tumors. [1994.01]
Two-layer membrane model for iontophoretic drug transport through excised rat skin. [1993.06]
Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation. [1993.02]
Liquid chromatographic determination of efficacy of incorporation of trimethoprim and sulfamethoxazole in brine shrimp (Artemia spp.) used for prophylactic chemotherapy of fish. [1991.12]
Binding inhibitors restore furosemide potency in tubule fluid containing albumin. [1991.09]
Nocardial brain abscesses in a pregnant woman. [1991.07]
Nocardia asteroides pericarditis: report of a case and review of the literature. [1990.06]
Proguanil-sulphonamide for malaria prophylaxis. [1990.01]
Treatment of chlamydial infections of the cervix during pregnancy. [1989.04]
Trimethoprim in the treatment of acute urinary tract infections in children. [1988.02]
Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. [2007.08]
Changes in antimicrobial susceptibility in a population of Escherichia coli isolated from feedlot cattle administered ceftiofur crystalline-free acid. [2007.05]
Prevalence of Escherichia coli O157 in Saskatchewan cattle: characterization of isolates by using random amplified polymorphic DNA PCR, antibiotic resistance profiles, and pathogenicity determinants. [2006.06]
Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia. [2006.05.15]
Multidrug resistance and distribution of Salmonella serovars in slaughtered pigs. [2006.02]
Antimicrobial resistance of Escherichia coli strains isolated from urine of women with cystitis or pyelonephritis and feces of dogs and healthy humans. [2004.08.01]
Changes in the prevalence of resistant Escherichia coil in cattle receiving subcutaneously injectable oxytetracycline in addition to in-feed chlortetracycline compared with cattle receiving only in-feed chlortetracycline. [2002.07]
Occurrence and characterization of resistance to extended-spectrum cephalosporins mediated by beta-lactamase CMY-2 in Salmonella isolated from food-producing animals in Canada. [2002.07]
Bilirubin-albumin binding and free bilirubin. [2001.12]
Neonatal mouse model: review of methods and results. [2001]
treatment and prevention of otitis media. [2000.12]
Urinary tract infections during pregnancy. [2000.02.01]
Antimicrobial susceptibility of Nocardia nova isolated from five cats with nocardiosis. [1999.09.15]
Pathogens isolated during treatment failures in otitis. [1998.10]
What role for antibiotics in otitis media and sinusitis? [1998.09]
A double-blind taste comparison of pediatric antibiotic suspensions. [1997.04]
Pharmacoeconomic impact of factors affecting compliance with antibiotic regimens in the treatment of acute otitis media. [1997.02]
Antimicrobials prescribed for otitis media in a pediatric Medicaid population. [1996.12.15]
A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children. [1996.01]
Therapeutic implications in the treatment of aural Pseudomonas infections based on in vitro susceptibility patterns. [1995.09]
Inhibition of recombinant Pneumocystis carinii dihydropteroate synthetase by sulfa drugs. [1995.08]
Immune response to sulfamethoxazole in patients with AIDS. [1995.03]
Disseminated subcutaneous Mycobacterium fortuitum infection in a dog. [1995.01.01]
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model. [1994.10]
Antimycobacterial drugs. [1994.06]
Preventing otitis media. [1994.05]
Antimicrobial therapy of pediatric patients with sinusitis. [1992.09]
Treatment of otitis media. [1992.01]
Multiple antibiotic sensitivity in a pediatric population. [1991.09]
Current treatment of otitis media in children. [1991.06]
Antimicrobial treatment of otitis media. [1991.06]
Cefmenoxime and bilirubin: competition for albumin binding. [1991.05]
[Choice of antibiotic treatment in otitis media] [1990.12.01]
Oral cephalosporins in perspective. [1990.01]
Preliminary characterization of a food-borne multiple-antibiotic-resistant Salmonella typhimurium strain. [1989.09]
In vitro antimicrobial activity of sulfonamides against some porcine pathogens. [1989.07]
Erythromycin-induced immune hemolytic anemia. [1988]
The first case of keratitis caused by Nocardia exalbida. [2007.10]
Associations between reported on-farm antimicrobial use practices and observed antimicrobial resistance in generic fecal Escherichia coli isolated from Alberta finishing swine farms. [2009.03.01]
Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections. [2008.09.18]
Genotype, serotype, and antibiotic resistance of sorbitol-negative Escherichia coli isolates from feedlot cattle. [2009.01]
Displacement of bilirubin from albumin by ibuprofen in vitro. [2010.06]
[New developments in glaucoma medical treatment] [2009.10]
Human metapneumovirus: an emerging respiratory pathogen. [2010.05]
|